Pharmaceutical giant reveals it is partnering with Honeywell to develop a new inhaler propellant that has 99.9 per cent less Global Warming Potential than current models
It may be one of the most surprising sources of greenhouse gas emissions, but now pharmaceutical giant AstraZeneca thinks it has worked out to tackle the climate damage caused by respiratory inhalers....
To continue reading this article...
Join BusinessGreen
- Enjoy exclusive news, insights and analysis from Europe’s leading source of information on the green economy and business.
- Make smart, responsible business decisions with an eye on the latest regulatory and tech developments
- Stay in the know with our overnight briefing, expertly curated help you run a competitive and sustainable business
- Tap into our extensive archive of exclusive articles, news, analysis and guides
- Access our Intelligence Reports and exclusive data-rich studies on business-critical aspects of the green economy (BG Advanced members only)
- Choose from 3 paid membership levels or start a 7-day no strings trial
